Latest Patents

Patents imply intellectual property and it has a $ value that can be associated depending on the field and type of patent that is allocated. Patents also increase the enterprise value of the company and help prevent copy-cats from copying the idea without having royalt payments or licencing deals. We like it when companies get patents awarded!. To protect IP companies aggressively file provisional patents even before they have a working product. The below table provides a way to look at what has been done by companies and use this as a factor to make investment decisions.

     
Title Filing Date Publication Date Grant Date
Indolinone compounds and uses thereof 2022-6-02 2022-9-15
Uses of indolinone compounds 2022-3-28 2022-11-17
Selective androgen receptor degrader (sard) ligands and methods of use thereof 2022-3-14 2023-2-09
Compounds for treatment of cancer 2021-7-22 2021-8-31
Compounds for treatment of cancer 2021-7-08 2022-1-27
Indole analogues and uses thereof 2021-3-26 2023-5-09 2023-5-09
Combinations of EGFR inhibitors and ROR1 inhibitors for the treatment of cancer 2021-1-29 2022-9-01
A method of treating breast cancers with selective androgen receptor modulator … 2020-9-14 2021-4-02
Selective androgen receptor degrader (SARD) ligands and methods of use thereof 2020-1-29 2023-2-28 2023-2-28
Selective androgen receptor degrader (sard) ligands and methods of use thereof 2019-10-04 2020-4-09
A method of treating er mutant expressing breast cancers with selective … 2019-7-31 2020-2-06
Selective androgen receptor degrader (sard) ligands and methods of use thereof 2019-5-16 2021-7-01
Non-invasive method of evaluating breast cancers for selective androgen … 2019-1-08 2019-5-02
Substituted imidazole based compounds for treatment of cancer 2018-9-19 2020-9-30
Selective androgen receptor degrader (SARD) ligands and methods of use thereof 2018-9-05 2020-12-15 2020-12-15
METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs 2018-3-05 2018-12-13
METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs 2018-3-02 2018-11-15
Compounds for treatment of cancer 2018-1-16 2019-3-28
METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs 2017-9-13 2018-6-28
Nuclear receptor binding agents 2016-12-19 2017-4-20
Method of treating HER2-positive breast cancers with selective androgen … 2016-12-06 2019-6-11 2019-6-11
Solid forms of selective androgen receptor modulators 2016-11-24 2017-9-21
Selective androgen receptor degrader (sard) ligands and methods of use thereof 2016-10-21 2017-6-15
Selective androgen receptor degrader (sard) ligands and methods of use thereof 2016-10-21 2017-5-18
Compounds for treatment of cancer 2016-9-20 2017-8-10
Compounds for treatment of cancer 2016-8-25 2017-1-12
Selective androgen receptor degrader (SARD) ligands and methods of use thereof 2016-7-28 2018-7-10 2018-7-10
Selective androgen receptor degrader (sard) ligands and methods of use thereof 2016-4-21 2018-2-28
Selective androgen receptor degrader (sard) ligands and methods of use thereof 2016-4-21 2016-10-27
Method of treating HER2-positive breast cancers with selective androgen … 2016-3-21 2019-4-16 2019-4-16
Nuclear receptor binding agents 2016-2-09 2017-1-19
Compounds for treatment of cancer 2015-9-18 2017-3-02 2017-3-02
Nuclear receptor binding agents 2015-8-05 2016-1-14
Method of treating androgen receptor (ar) -positive breast cancers with … 2015-7-13 2016-5-12
Estrogen receptor ligands and methods of use thereof 2015-6-08 2016-2-04
Compounds for treatment of cancer 2015-5-25 2015-6-11
Compounds for treatment of cancer 2015-4-21 2018-4-05
Estrogen receptor ligands and methods of use thereof 2014-10-24 2017-4-18 2017-4-18
Method of treating androgen receptor (ar) -positive breast cancers with … 2014-6-02 2014-11-27
Nuclear receptor binding agents 2014-2-24 2014-9-11
Solid forms of selective androgen receptor modulators 2014-1-17 2014-7-24
Estrogen receptor ligands and methods of use thereof 2013-12-23 2014-7-03
Estrogen receptor ligands and methods of use thereof 2013-10-01 2015-6-09 2015-6-09
Nuclear receptor binding agents 2013-8-23 2016-5-19 2016-5-19
Method of treating estrogen receptor (er) -positive breast cancers with … 2013-7-29 2014-3-20
Substituted acylanilides and methods of use thereof 2013-4-23 2013-12-05
Estrogen receptor ligands and methods of use thereof 2013-2-13 2014-2-27
Estrogen receptor ligands and methods of use thereof 2012-12-13 2014-2-27
Pharmaceutical compositions of selective androgen receptor modulators and … 2012-11-01 2013-5-23
Nuclear receptor binding agents 2012-10-15 2013-6-13
Estrogen receptor ligands and methods of use thereof 2012-8-23 2013-5-23
Nuclear receptor binding agents 2012-1-31 2014-1-28 2014-1-28
Nuclear receptor binding agents 2011-9-23 2012-9-27 2012-9-27
Compounds for treatment of cancer 2011-8-24 2012-3-22
Estrogen receptor ligands and methods of use thereof 2011-8-23 2016-8-30 2016-8-30
Methods of treating meibomian gland dysfunction 2011-1-11 2013-8-28
Treatment of bone related diseases with selective androgen receptor modifier 2010-9-23 2010-12-16
Treatment of muscle wasting with selective androgen receptor modulator 2010-7-23 2010-11-11
Treating benign prostate hyperplasia with sarm 2010-5-10 2010-9-24
Estrogen receptor ligands and methods of use thereof 2010-2-23 2010-8-26
Estrogen receptor ligands and methods of use thereof 2010-2-23 2016-5-12 2016-5-12
Metabolites of selective androgen receptor modulators and methods of use … 2009-6-19 2011-8-23 2011-8-23
Prodrugs of selective androgen receptor modulators and methods of use thereof 2008-11-14 2008-12-04
Treatment of androgen-deprivation induced osteoporosis 2008-9-19 2009-2-12
Prevention and treatment of androgen-deprivation induced osteoporosis 2008-7-15 2008-8-07
Prevention and treatment of gynecomastia or hot flashes 2008-3-12 2008-4-03
Treatment of androgen-deprivation induced osteoporosis 2008-2-22 2008-10-09
Prevention and treatment of androgen-deprivation induced skeletal-related event … 2007-1-25 2009-10-07
Selective estrogen receptor modulator reducing lipide characteristic 2006-12-21 2008-6-25
Method for improving lipid state with serm 2006-12-20 2008-7-10
Nuclear receptor binding agents 2006-11-28 2012-10-03
Treating renal disease, burns, wounds and spinal cord injury with selective … 2006-8-28 2007-3-22
Prevention and treatment of androgen-deprivation induced osteoporosis 2006-1-11 2006-11-30
Treating Androgen Decline in Aging Male (ADAM)- associated conditions with … 2006-1-04 2006-12-07
COMPOSITIONS COMPRISING 5-ALPHA REDUCTASE INHIBITORS, AND SERMs AND METHODS OF … 2005-7-21 2010-3-17
Prevention and treatment of androgen-deprivation induced conditions 2005-5-16 2005-6-02
Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and … 2004-12-06 2006-12-21
Anti-cancer compounds and methods of use thereof 2004-10-14 2005-9-22
Treating bone-related disorders with selective androgen receptor modulators 2004-10-12 2006-9-20
Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of … 2004-7-20 2006-11-16
Treating muscle wasting with selective androgen receptor modulators 2004-6-07 2010-6-10
Prevention and treatment of androgen—deprivation induced osteoporosis 2004-2-17 2009-4-28 2009-4-28
Methods for treating hot flashes 2004-2-17 2004-10-28
A method of treating breast cancer with androgen receptor antagonists 2004-1-20 2005-11-16
Treating androgen deficiency in female (adif)-associated conditions with sarms 2004-1-20 2005-11-16
Large-scale synthesis of selective androgen receptor modulators 2004-1-12 2013-8-22 2013-8-22
Methods for treating hot flashes and gynecomastia 2003-12-30 2004-10-28
Treating androgen decline in aging male (adam)-associated conditions with sarms 2003-10-14 2004-5-04
Treating obesity with selective androgen receptor modulators 2003-10-14 2004-5-04
Prevention and treatment of androgen-deprivation induced osteoporosis 2003-7-01 2004-5-20
Selective androgen receptor modulators and methods of use thereof 2001-8-23 2002-3-04
Selective androgen receptor modulators and methods of use thereof 2001-8-23 2002-12-10 2002-12-10